Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions.


Journal

Clinical pharmacology and therapeutics
ISSN: 1532-6535
Titre abrégé: Clin Pharmacol Ther
Pays: United States
ID NLM: 0372741

Informations de publication

Date de publication:
08 2021
Historique:
received: 18 12 2020
accepted: 22 03 2021
pubmed: 19 4 2021
medline: 26 8 2021
entrez: 18 4 2021
Statut: ppublish

Résumé

Adverse drug reaction (ADR) reporting is a major component of drug safety monitoring; its input will, however, only be optimized if systems can manage to deal with its tremendous flow of information, based primarily on unstructured text fields. The aim of this study was to develop an automated system allowing to code ADRs from patient reports. Our system was based on a knowledge base about drugs, enriched by supervised machine learning (ML) models trained on patients reporting data. To train our models, we selected all cases of ADRs reported by patients to a French Pharmacovigilance Centre through a national web-portal between March 2017 and March 2019 (n = 2,058 reports). We tested both conventional ML models and deep-learning models. We performed an external validation using a dataset constituted of a random sample of ADRs reported to the Marseille Pharmacovigilance Centre over the same period (n = 187). Here, we show that regarding area under the curve (AUC) and F-measure, the best model to identify ADRs was gradient boosting trees (LGBM), with an AUC of 0.93 (0.92-0.94) and F-measure of 0.72 (0.68-0.75). This model was run for external validation showing an AUC of 0.91 and a F-measure of 0.58. We evaluated an artificial intelligence pipeline that was found able to learn how to identify correctly ADRs from unstructured data. This result allowed us to start a new study using more data to further improve our performance and offer a tool that is useful in practice to efficiently manage drug safety information.

Identifiants

pubmed: 33866552
doi: 10.1002/cpt.2266
pmc: PMC8359992
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

392-400

Informations de copyright

© 2021 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.

Références

Drug Saf. 2020 Jan;43(1):57-66
pubmed: 31605285
J Healthc Eng. 2017;2017:7983473
pubmed: 29214005
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
Stud Health Technol Inform. 2020 Jun 16;270:1227-1228
pubmed: 32570592
Ultrasound Obstet Gynecol. 2006 Jun;27(6):607-8
pubmed: 16715467
Bull World Health Organ. 2018 Jan 1;96(1):66-68
pubmed: 29403102
Neural Comput. 1997 Nov 15;9(8):1735-80
pubmed: 9377276
J Clin Epidemiol. 2016 Jan;69:245-7
pubmed: 25981519
Expert Opin Drug Saf. 2018 Jul;17(7):681-695
pubmed: 29952667
BMJ. 2004 Jul 3;329(7456):15-9
pubmed: 15231615
Nat Biotechnol. 2015 Sep;33(9):921-4
pubmed: 26348958
Clin Infect Dis. 2018 Jan 6;66(1):149-153
pubmed: 29020316
Lancet. 2014 Jul 5;384(9937):8-9
pubmed: 24998803
Clin Pharmacol Ther. 2019 Apr;105(4):954-961
pubmed: 30303528
Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):725-32
pubmed: 26799344
Prescrire Int. 2016 Oct;25(175):247-250
pubmed: 30645835
J Healthc Eng. 2018 May 22;2018:6275435
pubmed: 29951182
JAMA. 1998 Apr 15;279(15):1200-5
pubmed: 9555760
Ann Intern Med. 2004 May 18;140(10):795-801
pubmed: 15148066
Trends Pharmacol Sci. 2019 Sep;40(9):624-635
pubmed: 31383376
JAMA. 2019 Nov 12;322(18):1806-1816
pubmed: 31714992
PLoS One. 2015 Mar 04;10(3):e0118432
pubmed: 25738806

Auteurs

Louis Létinier (L)

INSERM, BPH, U1219, Team Pharmacoepidemiology, Univ. Bordeaux, Bordeaux, France.
CHU de Bordeaux, Pole de Santé Publique, Service de Pharmacologie Médicale, Centre de Pharmacovigilance de Bordeaux, Bordeaux, France.
Synapse Medicine, Bordeaux, France.

Julien Jouganous (J)

Synapse Medicine, Bordeaux, France.

Mehdi Benkebil (M)

Surveillance Division, Agence nationale de sécurité du médicament et des produits de santé (ANSM), Saint Denis, France.

Alicia Bel-Létoile (A)

Synapse Medicine, Bordeaux, France.

Clément Goehrs (C)

Synapse Medicine, Bordeaux, France.

Allison Singier (A)

INSERM, BPH, U1219, Team Pharmacoepidemiology, Univ. Bordeaux, Bordeaux, France.

Franck Rouby (F)

CRPV Marseille Provence Corse, Service Hospitalo-Universitaire de Pharmacologie Clinique et Pharmacovigilance, Assistance Publique Hôpitaux de Marseille, Marseille, France.
Institut des Neurosciences des Systèmes, INSERM 1106, Aix Marseille Université, Marseille, France.

Clémence Lacroix (C)

CRPV Marseille Provence Corse, Service Hospitalo-Universitaire de Pharmacologie Clinique et Pharmacovigilance, Assistance Publique Hôpitaux de Marseille, Marseille, France.
Institut des Neurosciences des Systèmes, INSERM 1106, Aix Marseille Université, Marseille, France.

Ghada Miremont (G)

INSERM, BPH, U1219, Team Pharmacoepidemiology, Univ. Bordeaux, Bordeaux, France.
CHU de Bordeaux, Pole de Santé Publique, Service de Pharmacologie Médicale, Centre de Pharmacovigilance de Bordeaux, Bordeaux, France.

Joëlle Micallef (J)

CRPV Marseille Provence Corse, Service Hospitalo-Universitaire de Pharmacologie Clinique et Pharmacovigilance, Assistance Publique Hôpitaux de Marseille, Marseille, France.
Institut des Neurosciences des Systèmes, INSERM 1106, Aix Marseille Université, Marseille, France.

Francesco Salvo (F)

INSERM, BPH, U1219, Team Pharmacoepidemiology, Univ. Bordeaux, Bordeaux, France.
CHU de Bordeaux, Pole de Santé Publique, Service de Pharmacologie Médicale, Centre de Pharmacovigilance de Bordeaux, Bordeaux, France.

Antoine Pariente (A)

INSERM, BPH, U1219, Team Pharmacoepidemiology, Univ. Bordeaux, Bordeaux, France.
CHU de Bordeaux, Pole de Santé Publique, Service de Pharmacologie Médicale, Centre de Pharmacovigilance de Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH